Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2095179 Target Snapshot

Adenylate cyclase · PROTEIN FAMILY · Rattus norvegicus

106Compounds
38Assays
6Approved Drugs
31.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt D4A3N4. Use UniProt D4A3N4 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt D4A3N4 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Adenylate cyclase as ChEMBL target CHEMBL2095179, mapped to UniProt D4A3N4. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Adenylate cyclase
PROTEIN FAMILY · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL2095179
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
D4A3N4
Adenylate cyclase type 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Adenylate cyclase is the right protein anchor across sources, using UniProt D4A3N4 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelAdenylate cyclase type 1
UniProt AccessionD4A3N4
Component TypeProtein
Sequence Length1119 aa

Adenylate cyclase type 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Adenylate cyclase, mapped to UniProt D4A3N4. ChEMBL maps the protein component as Adenylate cyclase type 1. Sequence length is 1119 aa.

Mapped IDD4A3N4
Review nameAdenylate cyclase
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

6
Approved
Assay Mix

Activity Type Distribution

IC508.0
KI4.0
EC5017.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL412488 9.57 EC50 0.27 Preclinical
CHEMBL437648 8.28 Kd 5.248 Preclinical
CHEMBL428460 8.26 Kd 5.495 Preclinical
CHEMBL439885 8.2 EC50 6.3 Preclinical
CHEMBL552736 7.66 Ki 22.0 Preclinical
CHEMBL269490 7.64 EC50 23.0 Preclinical
CHEMBL1467585 7.5 EC50 32.0 Preclinical
CHEMBL369006 7.48 Ki 33.0 Preclinical
CHEMBL263603 7.38 EC50 41.8 Preclinical
CHEMBL442135 7.33 EC50 47.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
3
5.5
2
6.0
7
6.5
6
7.0
3
7.5
3
8.0
0
8.5
0
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

CLOZAPINE
CHEMBL42
Approved 1989
FLUPHENAZINE
CHEMBL726
Approved 1959
CHLORPROMAZINE
CHEMBL71
Approved 1957
Assay Landscape

Assay Landscape

41
Total Assays
25
Tested Compounds
2
Assay Types
Binding — 38 assays, 25 compounds
BAO Format Assays Compounds Avg pChEMBL
protein format 25 14 7.0
assay format 7 10 6.6
tissue-based format 6 1 7.1
Functional — 3 assays, 4 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 3 4 6.1

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine